News Center
Lizhu 2022 S&P CSA ESG rating results announced, industry leader
Release time:
2022-11-28
Recently, the results of the S&P CSA ESG score for Lizhu in 2022 were announced. As of November 18, 2022, Lizhu's S&P CSA ESG score improved from 22 points in 2021 to
42 points, (the global industry average score is 20 points),
surpassing over 90% of participating peers globally.Currently, about 6,700 companies worldwide have been invited to participate in the S&P CSA ESG assessment.
In 2022, Lizhu was also rated MSCI ESG AA, Wind ESG AA, ranked among the top 10 in the healthcare industry for Wind A-share and Hong Kong-listed companies ESG ratings, and recognized in the "2022 Top 20 ESG Competitiveness of Chinese Pharmaceutical Listed Companies" among other honors. The significant improvement in this S&P CSA ESG score further confirms Lizhu's outstanding performance in ESG management and its wide recognition globally.
Since 2016, the company has disclosed ESG reports for six consecutive years. Lizhu has always placed great importance on ESG management and is committed to continuously improving ESG governance. The highest decision-making body for ESG management has been elevated to the board of directors, and carbon reduction and carbon neutrality goals have been established. At the same time, the company systematically reviews and improves all aspects of its operations, laying a solid development foundation for sustainable development through top-down policy promotion and effective improvement actions.
Lizhu has always taken "the quality of patient life first" as its mission and "to be a leader in the pharmaceutical industry" as its vision. While seeking sustainable development, it actively practices corporate social responsibility, supports rural revitalization, and promotes common prosperity. In the future, Lizhu will adhere to a healthy, long-term, and sustainable development strategy, steadily enhance various ESG management efforts, explore green transformation, and actively promote the sustainable and healthy development of the group.
Related Information